Headline:

Report on the results of the Exercise of DOD-W2(F53-5) (Revision)

Security Symbol:

DOD

Announcement Details

Report on the results of sale of securities (F53-5)

Name of Company DOD BIOTECH PUBLIC COMPANY LIMITED

Date 31-May-2022

Report on the results of the exercise of warrants as follows

Number of

Number of

Ratio

Exercise

Number of shares derived

Number of remaining

Name of warrant

exercised

unexercised

(Warrant :

Price

Exercise Date

from exercised warrants

shares reserved

warrants (units)

warrants (units)

shares)

(baht/share)

(shares)

(shares)

Warrant of DOD BIOTECH

1

205,000,243

1.00 : 1.00

18.00

From

1

205,000,243 (Update)

PUBLIC COMPANY LIMITED No.

(Update)

31-May-2022 to

2(DOD-W2)

31-May-2022

Summary

Total excercised shares / converted shares (common

1

shares)

Signature ________________________________

(Miss Suwarin Konthong)

Director

Authorized to sign on behalf of the company

This announcement was prepared and disseminated by listed company or issuer through the electronic system which is provided for the purpose of dissemination of the information and related documents of listed company or issuer to the Stock Exchange of Thailand only. The Stock Exchange of Thailand has no responsibility for the correctness and completeness of any statements, figures, reports or opinions contained in this announcement, and has no liability for any losses and damages in any cases. In case you have any inquiries or clarification regarding this announcement, please directly contact listed company or issuer who made this announcement.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

DOD Biotech pcl published this content on 16 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 June 2022 06:32:10 UTC.